Abbott Laboratories and the United States Department of Defense are collaborating to develop a test that can be used to assess potential concussions quickly in the field. Abbott's handheld diagnostic i-Stat System is already in use by the military; the test will be developed for use on it.
Speculation is building that Minneapolis-based Medtronic will modify its offer for Dublin-based Covidien.
Global med tech companies could soon face mounting competition in China, as the country's top health authority is calling for a new set of initiatives to promote homegrown products and jumpstart the domestic industry.
The FDA continued its attack on Enhancement Medical LLC's Expression intranasal splint, designating the product's July recall as Class I.
Patients implanted with heart rhythm devices that automatically send information about cardiac abnormalities to a telemonitoring center showed improved outcomes in heart failures and fewer deaths than those without the remote monitoring leads, according to a new study.
The FDA has approved TMJ NextGeneration, custom ear canal inserts that increase the volume of the ear canal when the jaw is closed, thereby discouraging the user from clenching the jaw and the surrounding muscles.
The MOVEO foundation funded a project that turned a complete surgery into an Oculus Rift 3-D visual experience for the first time.
Amid growing regulatory action to crack down on corporate tax inversions, a top U.S. senator is urging Hospira to keep its operations at home and abandon plans to move abroad for taxpaying purposes.
Foundation Medicine is teaming up with the MD Anderson Cancer Center in Texas for a new trial of the the Cambridge, MA-based company's molecular diagnostic cancer test that targets therapies matched to individual patients.
Medical device evaluation can only be as effective as the tools used to conduct the evaluation. The FDA has begun seeking applications for the Medical Device Development Tools Pilot Program to validate and review such tools in preparation for a final guidance on the topic.
New research hints at a step beyond 3D printing in making customized implants. Researchers are working on a new material that changes shape when heated and could be used to surgically fill gaps in bone.
A couple of major players are making moves to get wearable med tech a bit closer to reality. Intel has partnered with the Michael J. Fox Foundation to collect data via smartwatches on Parkinson's disease patients, tracking the progression of disease.
Wearable device companies have raised at least $38.5 million on crowdfunding sites Kickstarter and Indiegogo, and 3D printing companies at least $25.6 million, according to calculations by Matt Witheiler, general partner at Flybridge Capital Partners. The statistic includes more than 80 companies that have raised more than $100,000.
While medical device security against cyberattacks is low, some experts say the benefits of devices far outweigh the small possibility of serious attacks.
Like many medical device companies, Johnson & Johnson is waging patent battles on many fronts at once. Recently, two cases in which J&J was the defendant took interesting twists.
Silk Road Medical raked in $15 million in financing for its innovative transcarotid stent system, a device that provides a less-invasive approach to traditional stenting.
Sofinnova Ventures has created venture firm HealthQuest Capital. It's in the midst of raising up to $110 million and has started disclosing early investments. An official announcement about the new firm is coming soon.
Apple has discussed collaboration with several promiminent healthcare players as it prepares to roll out its HealthKit service, which is anticipated to be an element of the iPhone 6 that's planned for this fall. The players include Mount Sinai Hospital, the Cleveland Clinic, Johns Hopkins and electronic health records company Allscripts, according to Reuters.
GE Capital has lent Cardiva Medical $12.5 million to ramp up commercialization. The company hopes that the firm's Healthcare Financial Services unit will aid its efforts by bringing to the table its own medical device experience. Cardiva markets vascular closure products for use after catheterization including Vascade and Catalyst.
Expectations are high for the recently FDA-approved, donated lung preservation device, XVIVO Perfusion System with STEEN Solution.